IE
ENZY

Israel Englander’s Enzymotec Ltd ENZY Stock Holding History

Israel Englander’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-152,938
Closed -$1.07M – 3965
2016
Q3 		$1.07M Buy
152,938
+71,314
+87% +$572K ﹤0.01% 2238
2016
Q2 		$682K Sell
81,624
-8,846
-10% -$73.3K ﹤0.01% 2337
2016
Q1 		$817K Sell
90,470
-10,000
-10% -$87.1K ﹤0.01% 2285
2015
Q4 		$985K Sell
100,470
-46,674
-32% -$442K ﹤0.01% 2314
2015
Q3 		$1.33M Sell
147,144
-42,428
-22% -$379K ﹤0.01% 2137
2015
Q2 		$1.58M Sell
189,572
-20,981
-10% -$193K ﹤0.01% 2045
2015
Q1 		$1.52M Sell
210,553
-24,904
-11% -$176K ﹤0.01% 2109
2014
Q4 		$1.8M Buy
235,457
+13,557
+6% +$98.4K ﹤0.01% 2055
2014
Q3 		$1.48M Buy
221,900
+62,111
+39% +$670K ﹤0.01% 2058
2014
Q2 		$2.17M Sell
159,789
-212,269
-57% -$3.56M 0.01% 1716
2014
Q1 		$8.19M Buy
+372,058
New +$9.86M 0.02% 925

Other funds holding ENZY

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Israel Englander's ENZY Position: Q4 2016 in Review

Israel Englander sold out of Enzymotec Ltd (ENZY) in Q4 2016, closing a stake of 152,938 shares — an estimated $1.07M sold.

Israel Englander first reported a position in ENZY in Q1 2014 and held it in 11 quarters. The position peaked at $8.19M in Q1 2014. 32 funds tracked by Wall St. Rank hold ENZY as of Q4 2016.

  • Israel Englander reported no remaining Enzymotec Ltd position as of Q4 2016 after selling out during the quarter.
  • Israel Englander sold 152,938 Enzymotec Ltd shares in Q4 2016, an estimated $1.07M.
  • Israel Englander first reported a position in Enzymotec Ltd in Q1 2014 and held it in 11 quarters.
  • Israel Englander's Enzymotec Ltd position peaked at $8.19M in Q1 2014.
  • 32 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.